HORIZON PHARMA PLC's ticker is HZNPXXXX and the CUSIP is G4617B105. A total of 198 filers reported holding HORIZON PHARMA PLC in Q1 2016. The put-call ratio across all filers is 0.26 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $0 | – | 0 | – | 0.00% | – |
| Q1 2021 | $0 | – | 0 | – | 0.00% | – |
| Q4 2020 | $0 | – | 0 | – | 0.00% | – |
| Q3 2020 | $0 | – | 0 | – | 0.00% | – |
| Q2 2020 | $0 | – | 0 | – | 0.00% | – |
| Q1 2020 | $0 | -100.0% | 0 | -100.0% | 0.00% | – |
| Q4 2018 | $5,000 | -80.0% | 233 | -82.1% | 0.00% | -100.0% |
| Q3 2018 | $25,000 | – | 1,301 | +7127.8% | 0.00% | – |
| Q2 2018 | $0 | -100.0% | 18 | -82.0% | 0.00% | – |
| Q3 2017 | $1,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q2 2017 | $1,000 | -96.6% | 100 | -94.9% | 0.00% | -100.0% |
| Q1 2017 | $29,000 | -9.4% | 1,945 | -2.2% | 0.00% | -50.0% |
| Q4 2016 | $32,000 | -11.1% | 1,989 | -0.3% | 0.00% | 0.0% |
| Q3 2016 | $36,000 | -56.6% | 1,995 | -60.3% | 0.00% | -60.0% |
| Q2 2016 | $83,000 | +62.7% | 5,028 | +111.6% | 0.01% | +66.7% |
| Q4 2015 | $51,000 | – | 2,376 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadfin Capital, LLC | 5,664,219 | $83,717,000 | 10.14% |
| Consonance Capital Management LP | 6,218,903 | $91,915,000 | 9.63% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 10,944,988 | $161,767,000 | 6.24% |
| Rhenman & Partners Asset Management AB | 1,751,322 | $25,885,000 | 4.10% |
| SCOPIA CAPITAL MANAGEMENT LP | 9,686,262 | $143,163,000 | 2.64% |
| ARMISTICE CAPITAL, LLC | 850,000 | $12,563,000 | 2.59% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 2,959,258 | $43,738,000 | 2.40% |
| Proxima Capital Management, LLC | 246,311 | $3,640,000 | 2.22% |
| Beach Point Capital Management LP | 522,898 | $7,728,000 | 2.18% |
| GRAYBILL WEALTH MANAGEMENT, LTD. | 165,260 | $2,443,000 | 1.94% |